Incannex Healthcare Ltd Stock Net Income
| IXHL Stock | USD 1.98 0.01 0.51% |
Incannex Healthcare Ltd fundamentals help investors to digest information that contributes to Incannex Healthcare's financial success or failures. It also enables traders to predict the movement of Incannex Stock. The fundamental analysis module provides a way to measure Incannex Healthcare's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Incannex Healthcare stock.
| Last Reported | Projected for Next Year | ||
| Net Loss | -18.5 M | -17.5 M | |
| Net Loss | -18.5 M | -17.5 M | |
| Net Loss | -18 M | -17.1 M | |
| Net Loss | (1.14) | (1.20) | |
| Net Income Per E B T | 0.90 | 0.77 |
Incannex | Net Income |
Incannex Healthcare Ltd Company Net Income Analysis
Incannex Healthcare's Net income is the profit of a company for the reporting period, which is derived after taking revenues and gains and subtracting all expenses and losses. Net income is one of the most-watched numbers by money managers as well as individual investors.
Current Incannex Healthcare Net Income | (18.46 M) |
Most of Incannex Healthcare's fundamental indicators, such as Net Income, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Incannex Healthcare Ltd is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Incannex Net Income Driver Correlations
Understanding the fundamental principles of building solid financial models for Incannex Healthcare is extremely important. It helps to project a fair market value of Incannex Stock properly, considering its historical fundamentals such as Net Income. Since Incannex Healthcare's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Incannex Healthcare's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Incannex Healthcare's interrelated accounts and indicators.
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Incannex Accumulated Other Comprehensive Income
Accumulated Other Comprehensive Income |
|
Based on the recorded statements, Incannex Healthcare Ltd reported net income of (18.46 Million). This is 105.41% lower than that of the Biotechnology sector and significantly lower than that of the Health Care industry. The net income for all United States stocks is 103.23% higher than that of the company.
Incannex Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Incannex Healthcare's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Incannex Healthcare could also be used in its relative valuation, which is a method of valuing Incannex Healthcare by comparing valuation metrics of similar companies.Incannex Healthcare is currently under evaluation in net income category among its peers.
Incannex Healthcare Current Valuation Drivers
We derive many important indicators used in calculating different scores of Incannex Healthcare from analyzing Incannex Healthcare's financial statements. These drivers represent accounts that assess Incannex Healthcare's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Incannex Healthcare's important valuation drivers and their relationship over time.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Market Cap | 143.0M | 188.0M | 66.6M | 42.4M | 47.7M | 60.1M | |
| Enterprise Value | 140.6M | 181.1M | 40.8M | 20.9M | 42.2M | 57.5M |
Incannex Healthcare Institutional Holders
Institutional Holdings refers to the ownership stake in Incannex Healthcare that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Incannex Healthcare's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Incannex Healthcare's value.| Shares | Bank Of America Corp | 2024-06-30 | 207 | Jpmorgan Chase & Co | 2024-06-30 | 2.0 | Tower Research Capital Llc | 2024-06-30 | 0.0 | Virtu Financial Llc | 2024-06-30 | 0.0 | Tidal Investments Llc. | 2024-09-30 | 130 K | Advisorshares Investments, Llc | 2024-09-30 | 127 K | Old Mission Capital Llc | 2024-06-30 | 68.7 K | Morgan Stanley - Brokerage Accounts | 2024-06-30 | 59.7 K | Hrt Financial Llc | 2024-06-30 | 43.9 K | Bridgeway Capital Management, Llc | 2024-09-30 | 25 K | Citadel Advisors Llc | 2024-09-30 | 24.2 K |
Incannex Fundamentals
| Return On Equity | -1.15 | ||||
| Return On Asset | -0.57 | ||||
| Operating Margin | (538.33) % | ||||
| Current Valuation | 31.63 M | ||||
| Shares Outstanding | 17.64 M | ||||
| Shares Owned By Insiders | 25.86 % | ||||
| Shares Owned By Institutions | 4.13 % | ||||
| Number Of Shares Shorted | 49.2 K | ||||
| Price To Book | 5.28 X | ||||
| Price To Sales | 2,904 X | ||||
| Revenue | 12 K | ||||
| Gross Profit | 1.01 M | ||||
| EBITDA | (18.5 M) | ||||
| Net Income | (18.46 M) | ||||
| Cash And Equivalents | 37.5 M | ||||
| Cash Per Share | 0.68 X | ||||
| Total Debt | 373 K | ||||
| Current Ratio | 18.84 X | ||||
| Book Value Per Share | 0.64 X | ||||
| Cash Flow From Operations | (15.85 M) | ||||
| Short Ratio | 1.76 X | ||||
| Earnings Per Share | (1.36) X | ||||
| Beta | 2.21 | ||||
| Market Capitalization | 34.84 M | ||||
| Total Asset | 17.05 M | ||||
| Retained Earnings | (110.67 M) | ||||
| Working Capital | 10.58 M | ||||
| Net Asset | 17.05 M |
About Incannex Healthcare Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Incannex Healthcare Ltd's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Incannex Healthcare using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Incannex Healthcare Ltd based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Incannex Healthcare Piotroski F Score and Incannex Healthcare Altman Z Score analysis. You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Incannex Healthcare. If investors know Incannex will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Incannex Healthcare listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.36) | Revenue Per Share 0.001 | Quarterly Revenue Growth 0.296 | Return On Assets (0.57) | Return On Equity (1.15) |
The market value of Incannex Healthcare is measured differently than its book value, which is the value of Incannex that is recorded on the company's balance sheet. Investors also form their own opinion of Incannex Healthcare's value that differs from its market value or its book value, called intrinsic value, which is Incannex Healthcare's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Incannex Healthcare's market value can be influenced by many factors that don't directly affect Incannex Healthcare's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Incannex Healthcare's value and its price as these two are different measures arrived at by different means. Investors typically determine if Incannex Healthcare is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Incannex Healthcare's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.